IL-17A & IL-17F

IL-17A & IL-17F Overview

English NameInterleukin-17FApproved Drugs0
Drugs in Clinical Trials4Target SynonymCytokine ML-1,Interleukin-17F,IL17F,Interleukin 17F,IL-17F,CANDF6,ML-1,ML1
Highest Development StageNDA/BLA
English NameInterleukin-17F
Target SynonymCytokine ML-1,Interleukin-17F,IL17F,Interleukin 17F,IL-17F,CANDF6,ML-1,ML1
Approved Drugs0
Drugs in Clinical Trials4
Highest Development StageNDA/BLA

IL-17A & IL-17F Product List

  • Product Category

    Protein (3)

  • Product Status

    Launched (3)

  • Species

    Human (2)Mouse (1)

  • Tag

    His Tag & Avi Tag (1)His Tag & Strep Tag (1)His Tag (1)

  • Conjugate

    Biotin-labeled (1)Unconjugated (2)

IL-17A & IL-17F Background

Interleukin-17A (IL17A) is also known as cytotoxic T-lymphocyte-associated antigen 8 (CTLA8),which is a proinflammatory cytokine produced by activated T cells. IL17A can regulate the activities of NF-kappaB and mitogen-activated protein kinases. Also,IL17A can stimulate the expression of IL6 and cyclooxygenase-2 (PTGS2/COX-2), as well as enhance the production of nitric oxide (NO).Furthermore,IL17A has been found both in glycosylated and nonglycosylated forms. High levels of IL-17 are associated with several chronic inflammatory diseases including rheumatoid arthritis, psoriasis and multiple sclerosis.

IL-17A & IL-17F Synonyms

IL-17A,Interleukin-17A,CTLA-8,IL-17,IL-17F,Interleukin-17F,Cytokine ML-1,IL17A&IL17F

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
SonelokimabALX-0761; MSB-0010841; M-1095Phase 3 ClinicalAblynx NvPsoriasis; Arthritis, Psoriatic; Hidradenitis Suppurativa
Details
Recombinant human IL-17A/F humanized antibody (Livzon Pharmaceutical Group)LZM-012; LZM012; XKH004; XKH-004Phase 3 ClinicalBeijing Kanova Biomedical Technology Co Ltd, Livzon Pharmaceutical Group IncSpondylitis, Ankylosing; Psoriasis; Plaque psoriasis
Details
DMT-310DMT-310Phase 3 ClinicalDermataAcne Vulgaris; Rosacea
Details
HY-1770HY-1770; HT-17; HT17; YF02; HT25; GH02; HY1770Phase 1 ClinicalSuzhou Pharmavan Co LtdPlaque psoriasis; Dermatitis, Atopic
Details
  • Overview
  • Product List
  • Clinical Drug Information
Contact Us

[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521

[North America]: 1 Innovation Way, Newark, DE 19711, USA
[Switzerland]: ACRObiosystems AG, c/o Zug Dammstrasse Centre AG, Dammstrasse 19, 6300 Zug Switzerland